T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Clinical trials for T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to control Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-stage study tests the safety of combining two drugs, ruxolitinib and duvelisib, in people whose T- or NK-cell lymphoma has come back or stopped responding to treatment. About 70 participants will receive the drugs to find the best dose and see if the combination can co…
Matched conditions: T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New pill trial targets rare leukemia
Disease control Recruiting nowThis study is testing whether a pill called ruxolitinib can shrink tumors in adults with a rare blood cancer called T-cell large granular lymphocyte leukemia (T-LGLL). The drug works by blocking enzymes that cancer cells need to grow. Researchers will enroll 30 patients to see ho…
Matched conditions: T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA
Phase: PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC